Vancomycin Infusion Reaction - Moving beyond "Red Man Syndrome".

Saved in:
Bibliographic Details
Title: Vancomycin Infusion Reaction - Moving beyond "Red Man Syndrome".
Authors: Alvarez-Arango S; From the Divisions of Allergy and Clinical Immunology and of Clinical Pharmacology (S.A.A.) and the Department of Medicine (S.M.O.), Johns Hopkins University, and the Johns Hopkins Center for Health Equity (S.M.O.) - both in Baltimore; and the Department of Medicine, Brigham and Women's Hospital (T.D.S.), Harvard Medical School (T.D.S., K.G.B.), and the Division of Rheumatology, Allergy, and Immunology (C.M.B., K.G.B.), and the Edward P. Lawrence Center for Quality and Safety (K.G.B.), Massachusetts General Hospital - all in Boston., Ogunwole SM; From the Divisions of Allergy and Clinical Immunology and of Clinical Pharmacology (S.A.A.) and the Department of Medicine (S.M.O.), Johns Hopkins University, and the Johns Hopkins Center for Health Equity (S.M.O.) - both in Baltimore; and the Department of Medicine, Brigham and Women's Hospital (T.D.S.), Harvard Medical School (T.D.S., K.G.B.), and the Division of Rheumatology, Allergy, and Immunology (C.M.B., K.G.B.), and the Edward P. Lawrence Center for Quality and Safety (K.G.B.), Massachusetts General Hospital - all in Boston., Sequist TD; From the Divisions of Allergy and Clinical Immunology and of Clinical Pharmacology (S.A.A.) and the Department of Medicine (S.M.O.), Johns Hopkins University, and the Johns Hopkins Center for Health Equity (S.M.O.) - both in Baltimore; and the Department of Medicine, Brigham and Women's Hospital (T.D.S.), Harvard Medical School (T.D.S., K.G.B.), and the Division of Rheumatology, Allergy, and Immunology (C.M.B., K.G.B.), and the Edward P. Lawrence Center for Quality and Safety (K.G.B.), Massachusetts General Hospital - all in Boston., Burk CM; From the Divisions of Allergy and Clinical Immunology and of Clinical Pharmacology (S.A.A.) and the Department of Medicine (S.M.O.), Johns Hopkins University, and the Johns Hopkins Center for Health Equity (S.M.O.) - both in Baltimore; and the Department of Medicine, Brigham and Women's Hospital (T.D.S.), Harvard Medical School (T.D.S., K.G.B.), and the Division of Rheumatology, Allergy, and Immunology (C.M.B., K.G.B.), and the Edward P. Lawrence Center for Quality and Safety (K.G.B.), Massachusetts General Hospital - all in Boston., Blumenthal KG; From the Divisions of Allergy and Clinical Immunology and of Clinical Pharmacology (S.A.A.) and the Department of Medicine (S.M.O.), Johns Hopkins University, and the Johns Hopkins Center for Health Equity (S.M.O.) - both in Baltimore; and the Department of Medicine, Brigham and Women's Hospital (T.D.S.), Harvard Medical School (T.D.S., K.G.B.), and the Division of Rheumatology, Allergy, and Immunology (C.M.B., K.G.B.), and the Edward P. Lawrence Center for Quality and Safety (K.G.B.), Massachusetts General Hospital - all in Boston.
Source: The New England journal of medicine [N Engl J Med] 2021 Apr 08; Vol. 384 (14), pp. 1283-1286. Date of Electronic Publication: 2021 Apr 03.
Publication Type: Journal Article
Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1533-4406
DOI:10.1056/NEJMp2031891